drugset / Trial / NCT00950079

Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography

NCT00950079

Phase 4 Unknown 368 enrolled CardioVascular Research Foundation, Korea
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to determine whether sodium bicarbonate is superior to sodium chloride in preventing contrast induced nephropathy in diabetic patients undergoing coronary angiography or intervention.

Timeline

Start
2008-02
Primary completion
2009-08
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium bicarbonate Diagnostic / imaging agent 1 mg/kg
Comparator sodium chloride Unknown